Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease (vol 101, pg 801, 2019)

被引：30
|
作者：
Tabrizi, Sarah J.
Ghosh, Rhia
Leavitt, Blair R.
机构：
来源：
NEURON | 2019年 / 102卷 / 04期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
D O I：
10.1016/j.neuron.2019.05.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：899 / 899
页数：1
相关论文
共 50 条
  • [21] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [22] Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease
    Highet, Blake
    Dieriks, Birger Victor
    Murray, Helen C.
    Faull, Richard L. M.
    Curtis, Maurice A.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [23] Laquinimod, Huntington's disease, and disease modification
    Mestre, Tiago
    LANCET NEUROLOGY, 2024, 23 (03): : 220 - 221
  • [24] Huntington's disease: degradation of mutant huntingtin by autophagy
    Sarkar, Sovan
    Rubinsztein, David C.
    FEBS JOURNAL, 2008, 275 (17) : 4263 - 4270
  • [25] Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model
    Marchionini, Deanna M.
    Liu, Jeh-Ping
    Ambesi-Impiombato, Alberto
    Kerker, Kimberly
    Cirillo, Kim
    Bansal, Mukesh
    Mushlin, Rich
    Brunner, Daniela
    Ramboz, Sylvie
    Kwan, Mei
    Kuhlbrodt, Kirsten
    Tillack, Karsten
    Peters, Finn
    Rauhala, Leena
    Obenauer, John
    Greene, Jonathan R.
    Hartl, Christopher
    Khetarpal, Vinod
    Lager, Brenda
    Rosinski, Jim
    Aaronson, Jeff
    Alam, Morshed
    Signer, Ethan
    Munoz-Sanjuan, Ignacio
    Howland, David
    Zeitlin, Scott O.
    JCI INSIGHT, 2022, 7 (20)
  • [26] The Disease Protein Huntingtin and Neuronal Protein Aggregations in Huntington's Disease (HD)
    Rueb, Udo
    Vonsattel, Jean Paul G.
    Heinsen, Helmut
    Korf, Horst-Werner
    NEUROPATHOLOGY OF HUNTINGTON'S DISEASE: CLASSICAL FINDINGS, RECENT DEVELOPMENTS AND CORRELATION TO FUNCTIONAL NEUROANATOMY, 2015, 217 : 101 - 117
  • [27] Huntingtin-Lowering Therapies for Huntington Disease A Review of the Evidence of Potential Benefits and Risks
    Leavitt, Blair R.
    Kordasiewicz, Holly B.
    Schobel, Scott A.
    JAMA NEUROLOGY, 2020, 77 (06) : 764 - 772
  • [28] Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease
    Imbert, Marine
    Blandel, Florence
    Leumann, Christian
    Garcia, Luis
    Goyenvalle, Aurelie
    NUCLEIC ACID THERAPEUTICS, 2019, 29 (05) : 256 - 265
  • [29] Longitudinal Evaluation Of The First Mutant Huntingtin PET Radioligand As A Marker For mHTT Lowering Therapies For Huntington's Disease
    Bertoglio, D.
    Verhaeghe, J.
    De Lombaerde, S.
    Zajicek, F.
    Vasilkovska, T.
    Miranda, A.
    Gaertner, A.
    Huscher, B.
    Kakoulidou, A.
    Cardaun, I.
    Cornelius, A.
    Schwagarus, T.
    Van der Linden, A.
    Stroobants, S.
    Wang, Y.
    Skinbjerg, M.
    Dominguez, C.
    Khetarpal, V.
    Liu, L.
    Munoz-Sanjuan, I.
    Bard, J.
    Staelens, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S129 - S129
  • [30] HUNTINGTIN REGULATES CORTICAL DEVELOPMENT: CONSEQUENCES FOR HUNTINGTON'S DISEASE
    Barnat, Monia
    Humbert, Sandrine
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A24 - A25
12345